Babies, made to order: The ‘New York Times’ sounds the reproductive tech alarm

Noor Siddiqui is the founder of Orchid, a genetic testing company that “gives parents the power to protect their children before pregnancy begins,” by isolating potential monogenic diseases (from mutations of a single gene) and polygenic diseases (combined results from multiple genes) that in effect promise a perfectly healthy child for life, which is neither realistic nor human. In fact, the opening banner on the firm’s website touts its mission, which reads as a mandate: “Have healthy babies.” The moral imperative is clear: create your children in a laboratory’s petri dish. The price tag: $2,500 per embryo.
 

The post Babies, made to order: The ‘New York Times’ sounds the reproductive tech alarm appeared first on The Catholic Thing.

Source link